Do incompletely excised dermatofibromas require revision surgery?

Management of Incompletely Excised Dermatofibromas

Incompletely excised dermatofibromas do not require routine revision surgery, as they are benign lesions with minimal recurrence risk even with positive margins.

Key Clinical Distinction

The critical first step is ensuring the diagnosis is truly dermatofibroma and not dermatofibrosarcoma protuberans (DFSP), as these require vastly different management approaches:

• DFSP requires aggressive re-excision when margins are positive, with re-resection recommended whenever possible until clear margins are achieved 1, 2
• Dermatofibromas are benign and behave differently despite occasional histologic similarities 1, 3

Evidence for Conservative Management of Dermatofibromas

Recurrence Rates with Positive Margins

• Dermatofibromas demonstrate very low recurrence rates even when incompletely excised 4, 5
• In a cohort study of 23 facial dermatofibromas (the highest-risk location), 89% had positive margins but only 22% recurred over a mean 54-month follow-up 4
• Digital dermatofibromas showed that despite lesional tissue extending to dermal margins in 14 of 26 specimens, only one required re-excision in follow-up ranging from 2 months to 10 years 5
• Facial dermatofibromas, despite being difficult to fully excise, behave similarly to those elsewhere on the body with no local recurrences reported in one 22-year series 6

Clinical Behavior

• Dermatofibromas are common benign skin tumors that typically demonstrate benign behavior 4
• Even cellular dermatofibromas (CDFs), which have histologic patterns resembling malignancies, are benign despite their ability to occasionally recur 7
• Metastasis from dermatofibromas is extremely rare 4

Recommended Management Algorithm

1. Confirm Diagnosis

• Ensure pathology definitively confirms dermatofibroma, not DFSP 1, 3
• If any diagnostic uncertainty exists, consider immunohistochemical staining (CD34, Factor XIIIa) 1
• DFSP shows alternating ovoid-spindled nuclear morphology in 98% of cases (highly specific and sensitive), which is absent in dermatofibromas 3

2. Observation Strategy

• No routine re-excision for incompletely excised dermatofibromas 4, 5
• Clinical follow-up to monitor for recurrence 4
• Patient education about the benign nature and low recurrence risk

3. Consider Re-excision Only If:

• Clinical recurrence develops during follow-up 4
• Patient experiences symptoms (pain, functional impairment)
• Cosmetic concerns warrant intervention
• Diagnostic uncertainty persists despite immunohistochemistry

Special Considerations

High-Risk Locations

Facial and digital dermatofibromas warrant mention as they:

• Are more difficult to completely excise due to anatomic constraints 4, 5, 6
• Show higher rates of positive margins (89% for facial lesions) 4
• Still demonstrate acceptable recurrence rates without routine re-excision 4, 6
• Subcutaneous involvement increases recurrence risk (odds ratio 4.53) but does not mandate immediate re-excision 4

Cellular Variants

Cellular dermatofibromas have higher recurrence potential but:

• Remain fundamentally benign 7
• May warrant closer surveillance rather than prophylactic re-excision 7
• Currently lack definitive indicators for predicting recurrence 7

Critical Pitfall to Avoid

The most important pitfall is misdiagnosing DFSP as dermatofibroma, as DFSP requires aggressive surgical management with re-excision until negative margins are achieved 1, 2. DFSP has irregular, deep subclinical extensions and local recurrence rates of 0-60% if incompletely excised 1. When in doubt, immunohistochemistry and nuclear morphology analysis should be performed 1, 3.